Neurocrine Biosciences saw the highest growth of 0.99% in patent filings and 1.49% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.4% and grants by 1.32%. GlobalData’s DataBook provides a comprehensive analysis of Neurocrine Biosciences‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Neurocrine Biosciences has been focused on protecting inventions in European Patent Office(EPO) with nine publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 30% filings and 11% grants. The European Patent Office(EPO), United States(US), World Intellectual Property Organization(WIPO), and Israel(IL) patent Office are among the top ten patent offices where Neurocrine Biosciences is filings its patents. Among the top granted patent authorities, Neurocrine Biosciences has 17% of its grants in Spain(ES), 11% in European Patent Office(EPO) and 11% in Israel(IL).
Daiichi Sankyo and Corcept Therapeutics could be the strongest competitors for Neurocrine Biosciences
In terms of grant share, Neurocrine Biosciences stands first among its competitors followed by Daiichi Sankyo and Corcept Therapeutics.
Patents related to addiction and rare diseases lead Neurocrine Biosciences's portfolio
Neurocrine Biosciences has the highest number of patents in addiction followed by, rare diseases. For addiction, nearly 56% of patents were filed and no patents were granted in Q2 2024.
Hyperkinesia related patents lead Neurocrine Biosciences portfolio followed by tardive dyskinesia, and dyskinesia
Neurocrine Biosciences has highest number of patents in hyperkinesia followed by tardive dyskinesia, dyskinesia, petrochemicals, and alzheimer's disease. For hyperkinesia, nearly 7% of patents were filed and 34% of patents were granted in Q2 2024.
For comprehensive analysis of Neurocrine Biosciences's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
